Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Department of Pneumology, University Hospital Zurich, Zurich, Switzerland.
Ann Thorac Surg. 2018 Feb;105(2):379-385. doi: 10.1016/j.athoracsur.2017.09.006. Epub 2017 Dec 7.
Lung volume reduction surgery (LVRS) has been proven to be a successful procedure and can be performed with low mortality when defined selection criteria are met. We hypothesized good outcome and low mortality after LVRS for selected patients with severe hyperinflation and nonhomogeneous morphology even when diffusion capacity of the lung for carbon monoxide (Dlco) is less than 20%.
The study included all patients scheduled for LVRS between March 2005 and May 2014 with a preoperative Dlco of less than 20%. Postoperative 90-day mortality was the primary end point. Secondary end points were postoperative lung function and surgical morbidity at 3, 6, and 12 months.
Included were 33 patients with a median forced expiratory volume in 1 second of 23% (interquartile range, 19% to 28%), a median diffusion capacity of 15% (interquartile range, 13% to 18%), and a median hyperinflation of 76% (residual volume-to-total lung capacity ratio of 70% to 76%). Mean follow-up was 44.8 months (range, 10 to 141 months). Heterogeneous emphysema was present in 26 patients, and 7 showed intermediately heterogeneous morphology. Sixteen procedures were bilateral, and 31 were performed by video-assisted thoracoscopic surgery. The 90-day mortality was 0%. Median forced expiratory volume in 1 second percentage predicted at 3 months increased from 23% to 29% (p < 0.001). Median Dlco increased from 15% to 24% (p < 0.001), and median hyperinflation decreased from 76% to 63% (p < 0.001). A prolonged air leak exceeding 7 days occurred in 16 patients (48.5%), and 6 required reoperation for fistula closure. The 7 patients with intermediately heterogeneous emphysema showed a median increase in forced expiratory volume in 1 second from 20% preoperatively to 28% postoperatively (p = 0.028).
Selected patients with severely impaired Dlco of less than 20% can cautiously be considered as potential candidates if hyperinflation is severe and the lungs show areas with advanced destruction as targets for resection.
肺减容术(LVRS)已被证明是一种成功的手术,当满足明确的选择标准时,死亡率较低。我们假设即使一氧化碳弥散量(Dlco)小于 20%,对于严重过度充气和非均质性形态的选定患者,LVRS 后仍能获得良好的结果和低死亡率。
该研究纳入了 2005 年 3 月至 2014 年 5 月期间接受 LVRS 且术前 Dlco 小于 20%的所有患者。术后 90 天死亡率为主要终点。次要终点为术后 3、6 和 12 个月时的肺功能和手术发病率。
共纳入 33 例患者,第 1 秒用力呼气量中位数为 23%(四分位距,19%28%),Dlco 中位数为 15%(四分位距,13%18%),过度充气中位数为 76%(残气量/总肺容量比为 70%76%)。平均随访时间为 44.8 个月(范围,10141 个月)。26 例患者存在不均匀性肺气肿,7 例表现为中度不均匀形态。16 例为双侧手术,31 例为电视辅助胸腔镜手术。90 天死亡率为 0%。术后 3 个月第 1 秒用力呼气量百分比预计值中位数从 23%增加到 29%(p<0.001)。Dlco 中位数从 15%增加到 24%(p<0.001),过度充气中位数从 76%减少到 63%(p<0.001)。16 例(48.5%)患者出现持续 7 天以上的迁延性漏气,6 例需要再次手术以闭合瘘口。7 例中度不均匀性肺气肿患者术后第 1 秒用力呼气量中位数从术前的 20%增加到术后的 28%(p=0.028)。
对于严重 Dlco 受损且小于 20%、但过度充气严重且肺部显示有晚期破坏的区域作为切除目标的患者,可谨慎考虑为潜在候选者。